Vaginal microbicides: how do you kick-start a global market?
D000569:Americas; D019049:Developed Countries; D004194:Disease; D004467:Economics; D005062:European Union; D005376:Financial Management; D015658:HIV Infections; D007239:Infections; D009656:North America; D009938:Organizations; D004364:Pharmaceutical Preparations; D012106:Research; D012749:Sexually Transmitted Diseases; D013672:Technology; D013812:Therapeutics; D014481:United States; D014777:Virus Diseases
D004364:Pharmaceutical Preparations
Americas; Developed Countries; Diseases; Drugs; Economic Factors; European Community; Financial Activities; Funds; Hiv Infections--prevention and control; Hiv Infections--women; Infections; North America; Northern America; Organizations; Reproductive Tract Infections; Research And Development; Sexually Transmitted Diseases--prevention and control; Sexually Transmitted Diseases--women; Technology; Treatment; United States; Viral Diseases